共 50 条
[23]
FDA approves second microbiome-based C. difficile therapy
[J].
Nature Reviews Drug Discovery,
2023, 22
:436-436
[29]
FDA Approves Xeomin (incobotulinumtoxinA)
[J].
JOURNAL OF DRUGS IN DERMATOLOGY,
2011, 10 (09)
:1076-1076